Patents by Inventor Peter Buehlmayer

Peter Buehlmayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Valsartan salts
    Patent number: 9499499
    Abstract: The invention relates to new salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: November 22, 2016
    Assignee: Novartis AG
    Inventors: Erwin Marti, Hans Rudolf Oswald, Peter Buehlmayer, Wolfgang Marterer
  • BICYCLIC HETEROARYL CYCLOALKYLDIAMINE DERIVATIVES AS INHIBITORS OF SPLEEN TYROSINE KINASES (SYK)
    Publication number: 20160213670
    Abstract: The present invention relates to bicyclic heteroaryl cycloalkyldiamine derivatives, to processes for their production, to their use as SYK inhibitors and to pharmaceutical compositions comprising them.
    Type: Application
    Filed: April 1, 2016
    Publication date: July 28, 2016
    Inventors: Peter Buehlmayer, Alexander Baxter Smith, Gebhard Thoma, Maurice Van Eis
  • Bicyclic heteroaryl cycloalkyldiamine derivatives
    Patent number: 9315500
    Abstract: The present invention relates to bicyclic heteroaryl cycloalkyldiamine derivatives, to processes for their production, to their use as SYK inhibitors and to pharmaceutical compositions comprising them.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: April 19, 2016
    Assignee: NOVARTIS AG
    Inventors: Peter Buehlmayer, Alexander Baxter Smith, Gebhard Thoma, Maurice Van Eis
  • Bicyclic Heteroaryl Cycloalkyldiamine Derivatives
    Publication number: 20150218157
    Abstract: The present invention relates to bicyclic heteroaryl cycloalkyldiamine derivatives, to processes for their production, to their use as SYK inhibitors and to pharmaceutical compositions comprising them.
    Type: Application
    Filed: August 12, 2013
    Publication date: August 6, 2015
    Applicant: NOVARTIS AG
    Inventors: Peter Buehlmayer, Alexander Baxter Smith, Gebhard Thoma, Maurice Van Eis
  • VALSARTAN SALTS
    Publication number: 20140073677
    Abstract: The invention relates to new salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.
    Type: Application
    Filed: November 15, 2013
    Publication date: March 13, 2014
    Inventors: Erwin Marti, Hans Rudolf Oswald, Peter Buehlmayer, Wolfgang Marterer
  • 2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors
    Patent number: 8283356
    Abstract: Disclosed are pyrimidine derivatives of formula wherein R0, R1, R3 to R9, and Z have a signification as indicated in claim 1, which have interesting pharmaceutical properties.
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: October 9, 2012
    Assignee: Novartis AG
    Inventors: Rolf Baenteli, Marie Claude Bernhard, Peter Buehlmayer, Nigel Graham Cooke, Rudolf Duthaler, Klaus Hinterding, Gebhard Thoma, Maurice Van Eis, Anette Von Matt, Louis Walliser, Gerhard Zenke
  • Valsartan salts
    Patent number: 8278339
    Abstract: The invention relates to new salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.
    Type: Grant
    Filed: August 5, 2008
    Date of Patent: October 2, 2012
    Assignee: Novartis AG
    Inventors: Erwin Marti, Hans R Oswald, Peter Bühlmayer, Wolfgang Marterer
  • Indol-alanine derivatives as selective S1P4-agonists
    Patent number: 7754896
    Abstract: The present invention relates to agonists of the S1P4 receptor, which are selective for the S1P4 receptor over one or more of the S1P1, S1P2, S1P3 or S1P5 receptors of at least 10 fold, in particular new indol-alanine derivatives of structure I, process for their production, their uses, in particular in transplantation, and pharmaceutical compositions containing them wherein R1 is phenyl or naphthyl, wherein phenyl is substituted by one or two of halogen, C1-6alkyl, C1-6alkoxy or phenylC1-6alkyl; and R2 is hydrogen or C1-6alkyl; in free or salt form.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: July 13, 2010
    Assignee: Novartis AG
    Inventors: Kamal Azzaoui, Rochdi Bouhelal, Peter Buehlmayer, Danilo Guerini, Manuel Koller
  • 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
    Publication number: 20100152182
    Abstract: Disclosed are pyrimidine derivatives of formula wherein R0, R1, R3 to R9, and Z have a signification as indicated in claim 1, which have interesting pharmaceutical properties.
    Type: Application
    Filed: January 13, 2010
    Publication date: June 17, 2010
    Inventors: Rolf Baenteli, Marie Claude Bernhard, Peter Buehlmayer, Nigel Graham Cooke, Rudolf Duthaler, Klaus Hinterding, Gebhard Thoma, Maurice Van Eis, Anette Von Matt, Louis Walliser, Gerhard Zenke
  • 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
    Patent number: 7671063
    Abstract: Disclosed are pyrimidine derivatives of formula wherein R0, R1, R3 to R9, and Z have a signification as indicated in claim 1, which have interesting pharmaceutical properties.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: March 2, 2010
    Assignee: Novartis AG
    Inventors: Rolf Baenteli, Marie Claude Bernhard, Peter Buehlmayer, Nigel Graham Cooke, Rudolf Duthaler, Klaus Hinterding, Gebhard Thoma, Maurice Van Eis, Anette Von Matt, Louis Walliser, Gerhard Zenke
  • Lck inhibitors
    Publication number: 20100029636
    Abstract: The invention relates to novel pyrazolo[1,5-A]pyrimidine compounds of Formula I in which all the variables are as defined in the specification; to their preparation and to their use as Lck kinase inhibitors.
    Type: Application
    Filed: September 26, 2007
    Publication date: February 4, 2010
    Inventors: Peter Buehlmayer, Werner Breitenstein, Pascal Furet, Bernard Pirard, Anette von Matt, Thomas Zoller
  • Amino-propanol derivatives
    Patent number: 7612238
    Abstract: Compounds of formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: November 3, 2009
    Assignee: Novartis AG
    Inventors: Peter Buehlmayer, Klaus Hinterding, Carsten Spanka, Frédéric Zecri
  • Indol-Alanine Derivatives as Selective S1P4-Agonists
    Publication number: 20090023797
    Abstract: The present invention relates to agonists of the S1P4 receptor, which are selective for the S1P4 receptor over one or more of the S1P1, S1P2, S1P3 or S1P5 receptors of at least 10 fold, in particular new indol-alanine derivatives of structure 1, process for their production, their uses, in particular in transplantation, and pharmaceutical compositions containing them wherein R1 is phenyl or naphthyl, wherein phenyl is substituted by one or two of halogen, C1-6alkyl, C1-6alkoxy or phenylC1-6alkyl; and R2 is hydrogen or C1-6alkyl; in free or salt form.
    Type: Application
    Filed: January 20, 2005
    Publication date: January 22, 2009
    Inventors: Kamal Azzaoui, Rochdi Bouhelal, Peter Buehlmayer, Danilo Guerini, Manuel Koller
  • 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
    Publication number: 20060247262
    Abstract: Disclosed are pyrimidine derivatives of formula wherein R0, R1, R3 to R9, and Z have a signification as indicated in claim 1, which have interesting pharmaceutical properties.
    Type: Application
    Filed: March 16, 2006
    Publication date: November 2, 2006
    Inventors: Rolf Baenteli, Marie Bernhard, Peter Buehlmayer, Nigel Cooke, Rudolf Duthaler, Klaus Hinterding, Gebhard Thoma, Maurice Van Eis, Anette Von Matt, Louis Walliser, Gerhard Zenke
  • Amino-propanol derivatives
    Publication number: 20060166940
    Abstract: Compounds of formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 12, 2003
    Publication date: July 27, 2006
    Inventors: Peter Buehlmayer, Klaus Hinterding, Carsten Spanka, Frederic Zecri
  • Selective NPY (Y5) antagonists (tricyclics)
    Patent number: 6222040
    Abstract: This invention is directed to tricyclic compounds which are selective antagonists for NPY (Y5) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: April 24, 2001
    Assignee: Synaptic Pharmaceutical Corporation
    Inventors: Mohammad R. Marzabadi, Peter Bühlmayer, Heinrich Rüeger, Wai C. Wong, Yasuchika Yamaguchi, Stewart A. Noble